MYADM and pulmonary arterial hypertension: In summary, we have provided evidence that Myadm-induced PASMC proliferation plays a causal role in the development of PAH vascular remodeling via a KLF4 nuclear export-dependent mechanism, leading to a decreased p21/Cip1 expression level.